Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Strober B, van de Kerkhof PCM, Callis Duffin K, Poulin Y, Warren RB, de la Cruz C, van der Walt JM, Stolshek BS, Martin ML, de Carvalho AVE

Am J Clin Dermatol. 2019 Jun 21. doi: 10.1007/s40257-019-00458-2. [Epub ahead of print]

Patient-reported outcome measures are important tools for capturing the patient experience and enhancing the patient-physician interaction. The Psoriasis Symptom Inventory (PSI) is a validated, 8-item instrument that assesses the severity of patient-reported psoriasis signs and symptoms. In 2017, IPC developed and executed a global study in partnership with Amgen that evaluated the practical usefulness of the PSI in clinical settings. The findings showed that completing the PSI questionnaire and subsequent discussion of the score with their physician encouraged patients to better communicate their experiences and treatment goals. Ultimately, understanding patients’ perspectives of their psoriasis symptoms will lead to patient-focused disease management. More information will be posted on the IPC website later this year regarding the availability of the PSI for clinical research and practice.

You can view the full article HERE.


Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.